BULL CERTIFICATE - ORION B Share Price

Certificat

BULL ORION X5 N

SE0021769288

Market Closed - Bid/Ask			After market 08:55:00 pm
- ^EUR	-.--%		13.27	+∞%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ORION OYJ

Latest news about ORION OYJ

Orion Partners with Universities for Biotechnology Project in Finland	03/06	MT
Orion is developing the Finnish life science industry in a unique collaboration project	03/06	GL
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025	07/05	GL
Orion Corporation Announces Change in Orion Group Executive Management Board as of 31 May 2025	07/05	CI

More news

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	ORION OYJ
Issuer	Nordea
	BULL ORION X5 N
ISIN	SE0021769288
Date issued	30/04/2024
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Spread	0.12 €
Spread %	0.90%

Company Profile

Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (43.4%); - patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal health products (8.7%); - pharmaceutical ingredients and outsourcing services (6.2%). Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%). Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).

Sector

More about the company